Clinical Trials
Riverside is here for you during the COVID-19 outbreak.

For more information, please click here.

An Observational Study of Triple Negative Breast Cancer at a Community Hospital

The goal of this study is to collect information on how patients who have triple negative breast cancer present with the illness, and how they respond to the treatments they receive. There will be no changes to the treatment you will receive from your doctor. This study will not require you to undergo any specific treatment, tests or evaluations. Information regarding the history of your breast cancer, results of tests and treatments done will be collected from your medical record by the research staff. Twice a year for the duration of the study, updated information concerning your status and any intervening treatments will be collected.

Principal Investigator

William W. MacLaughlin, MD

Contact

Ora Mae Jackson, RN, OCN
757-534-5565

[email protected]

Locations

Peninsula Cancer Institute
12100 Warwick Blvd. Suite 201
Newport News, VA 23601

Peninsula Cancer Institute
201 King's Way, Suite 3100
Williamsburg, VA 23185

Peninsula Cancer Institute
7544B Medical Drive
Gloucester, VA 23061

Cancer Specialists of Tidewater
1200 First Colonial Road, #204
Virginia Beach, VA 23454

Cancer Specialists of Tidewater
110-E Wimbledon Square
Chesapeake, VA 23320

Cancer Specialists of Tidewater
5839 Harbour View Blvd., #100
Suffolk, VA 23435

Riverside Shore Cancer Center
20480 Market Street
Onancock, VA 23417
757-302-2600

Status

Recruiting

Category

Oncology

Study #

N/A